Evidence map›Paper›PMID 37112713›Full record

ArticleVaccines2023

Multi-Perspective Views and Hesitancy toward COVID-19 Vaccines: A Mixed Method Study.

Serine Sahakyan, Natella Gharibyan, Lusine Aslanyan, Varduhi Hayrumyan, Arusyak Harutyunyan, Lorky Libaridian, Zaruhi Grigoryan

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Serine SahakyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.ORCID 0000-0001-7743-290X
Natella GharibyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.
Lusine AslanyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.
Varduhi HayrumyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.ORCID 0000-0002-6868-8804
Arusyak HarutyunyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.
Lorky LibaridianCambridge Health Alliance, Harvard Medical School, Cambridge, MA 02139, USA.
Zaruhi GrigoryanTurpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia.
American University of Armenia · AMCambridge Health Alliance · US

Funding

United States Agency for International Development 72011120CA00003
6 · The paper itself

Abstract

The worldwide uptake of COVID-19 vaccines was suboptimal throughout the pandemic; vaccine hesitancy played a principle role in low vaccine acceptance both globally and in Armenia. In order to understand the factors behind the slow vaccine uptake in Armenia, we aimed to explore the prevailing perceptions and experiences of healthcare providers and the general public related to COVID-19 vaccines. The study applied a convergent parallel mixed-methods study design (QUAL-quant) through in-depth interviews (IDI) and a telephone survey. We completed 34 IDIs with different physician and beneficiary groups and a telephone survey with 355 primary healthcare (PHC) providers. The IDIs found that physicians held variable views on the need for COVID-19 vaccination which, combined with mixed messaging in the media landscape, fueled the public's vaccine hesitancy. The survey results were mostly consistent with the qualitative findings as 54% of physicians hypothesized that COVID-19 vaccines were rushed without appropriate testing and 42% were concerned about the safety of those vaccines. Strategies to improve vaccination rates must target the main drivers of hesitancy, such as physicians' poor knowledge of specific vaccines and spiraling misconceptions about them. Meanwhile, timely educational campaigns with targeted messaging for the general public should address misinformation, promote vaccine acceptance, and empower their capacity to make decisions about their health.

Indexed as

COVID-19healthcare providervaccine

Identifiers

PMID37112713
PMCPMC10147024
OpenAlexW4362611274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.